Product Information
AZITHROMYCIN I.V. 500 MG VIAL is a generic product labeled by Athenex Pharmaceutical Division, LLC., priced at $3.5270 per EA under NDC 70860010010. Its NADAC has been published 70 times since Dec 18, 2024.
FDA first approved this application on Nov 9, 2009. Its Orange Book therapeutic-equivalence code is AP.
Strength
500 mg/5mL
Manufacturer
Athenex Pharmaceutical Division, LLC.NDC
70860010010
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Effective Date
4/23/2025
Active Ingredients
AZITHROMYCIN MONOHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA065501FDA Approved
11/9/2009
TE Code
AP
On Market Since
1/1/2017
Pharmacological Classes
Price Statistics
The NADAC for AZITHROMYCIN I.V. 500 MG VIAL has been published 70 times since Dec 18, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.5270 per EA |
|---|---|
| All-time high | $3.5270 (Apr 15, 2026) |
| All-time low | $3.5270 (Dec 18, 2024) |
| 52-week high | $3.5270 |
| 52-week low | $3.5270 |
| Median price | $3.5270 |
| Average price | $3.5270 |
| Largest weekly change | 0.0% (Dec 25, 2024) |
| Weeks tracked | 70 |
| Tracking since | Dec 18, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Apr 15, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the azithromycin monohydrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Athenex Pharmaceutical Division, LLC. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
azithromycin monohydrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Macrolide Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AZITHROMYCIN I.V. 500 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for AZITHROMYCIN I.V. 500 MG VIAL, manufactured by Athenex Pharmaceutical Division, LLC., is $3.5270 per EA (NDC 70860010010), effective Apr 15, 2026.
How has the price of AZITHROMYCIN I.V. 500 MG VIAL changed over time?
Over the history we have for it, the NADAC for AZITHROMYCIN I.V. 500 MG VIAL has held within roughly two percent of its current level. It has been tracked across 70 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for AZITHROMYCIN I.V. 500 MG VIAL?
Since Dec 18, 2024, the NADAC for AZITHROMYCIN I.V. 500 MG VIAL has ranged from a low of $3.5270 (Dec 18, 2024) to a high of $3.5270 (Apr 15, 2026), with a median of $3.5270 per EA.
Are there cheaper alternatives to AZITHROMYCIN I.V. 500 MG VIAL?
No other NADAC-published product currently shares the active ingredient and strength of AZITHROMYCIN I.V. 500 MG VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AZITHROMYCIN I.V. 500 MG VIAL?
AZITHROMYCIN I.V. 500 MG VIAL (NDC 70860010010) is labeled by Athenex Pharmaceutical Division, LLC., and CMS classifies it as a generic product.